Move-HSP:遗传性痉挛性截瘫患者步态适应性训练随机对照试验方案
主要结局为Emory功能性步行量表障碍物子任务。
要点
- C-Mill训练为每周2次、每次1小时、共10次,持续5周。
- 主要结局采用Emory功能性步行量表障碍物子任务评估。
- 对照组在干预期后交叉接受相同C-Mill训练。
核心结论
- Move-HSP将是首个评估C-Mill步态适应性训练在单纯型HSP患者中效果的随机对照试验,为步态适应性训练疗效提供概念验证。
研究设计与样本
- 5周、两臂、开放标签随机对照试验,对照组采用交叉设计。
- 干预组接受10次C-Mill训练(每周2次,每次1小时,第17-21周),对照组继续常规护理。
- 对照组随后交叉接受10次C-Mill训练(第23-27周),两组均进行随访评估。
关键数值与推荐
- 主要结局为Emory功能性步行量表障碍物子任务。
- 次要结局包括平衡与步行能力临床测试、身体活动和跌倒监测。
- 所有参与者登记(接近)跌倒15周,并在第16周佩戴Activ8活动监测器7天。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with hereditary spastic paraplegia (HSP) experience difficulties adapting their gait to meet environmental demands, a skill required for safe and independent ambulation. Gait adaptability training is possible on the C-Mill, a treadmill equipped with augmented reality, enabling visual projections to serve as stepping targets or obstacles. It is unknown whether gait adaptability can be trained in people with HSP. AIM: The aim of Move-HSP is to study the effects of ten 1-h sessions of C-Mill training, compared with usual care, on gait adaptability in people with pure HSP. In addition, this study aims to identify key determinants of C-Mill training efficacy in people with pure HSP. METHOD: Move-HSP is a 5-week, two-armed, open-label randomized controlled trial with a cross-over design for the control group. Thirty-six participants with pure HSP will be included. After signing informed consent, participants are randomized (1:1) to intervention or control group. All participants register (near) falls for 15 weeks, followed by the first assessment (week 16), and, thereafter, wear an Activ8 activity monitor for 7 days (week 16). The intervention group receives 10 sessions of C-Mill training (twice per week, 1-h sessions; weeks 17-21), whereas control group continues with usual care (weeks 17-21). Afterwards, both groups are re-assessed (week 22). Subsequently, the intervention group enter follow-up, whereas control group receives 10 sessions of C-Mill training (weeks 23-27), is re-assessed (week 28), and enters follow-up. During follow-up, both groups wear Activ8 activity monitors for 7 days (intervention group: week 23, control group: week 29) and register (near) falls for 15 weeks (intervention group: weeks 23-37, control group: weeks 29-43), before the final assessment (intervention group: week 38, control group: week 44). The primary outcome is the obstacle subtask of the Emory Functional Ambulation Profile. Secondary outcomes consist of clinical tests assessing balance and walking capacity, physical activity, and fall monitoring. DISCUSSION: Move-HSP will be the first RCT to assess the effects of C-Mill gait adaptability training in people with pure HSP. It will provide proof of concept for the efficacy of gait adaptability training in people with pure HSP. TRIAL REGISTRATION: Clinicaltrials.gov NCT04180098 . Registered on November 27, 2019.
引用
- van de Venis L, van de Warrenburg BPC, Weerdesteyn V, et al. Improving gait adaptability in patients with hereditary spastic paraplegia (Move-HSP): study protocol for a randomized controlled trial. Trials. 2021. PMID: 33413555. doi:10.1186/s13063-020-04932-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。